Small caps round-up: BioSeek, 21st Century, CareCapital...

BioSeek, a subsidiary of drugs developer Asterand, has signed a new three-year collaboration agreement with Merck Serono, a division of German pharmaceuticals giant firm Merck. The new agreement is for a research plan which extends and expands the companies' previous three-year agreement from 2009. The studies carried out by BioSeek for Merck Serono over the past three years have demonstrated that the BioMAP platform can be used to reliably advance promising molecules through pre-clinical evaluation, the company claimed.

By MoneyWeek

Published 28 March 2012 In Features

21st Century, a supplier and installation service provider of public transport closed-circuit television, reported a leap in sales from £10.8m to £14m for 2011. Profit after tax doubled from £0.6m to £1.2m, while earnings per share rose from 0.61p to 1.31p. Year end cash was up to £2.8m from £1.1m at the start of the year. The firm said if the company continues to progress it will consider proposing a dividend within the next 12 months.

CareCapital, a property investment firm, has announced a restructing of the company to reflect its strategy to reposition the group as an investor in, and provider of, advanced cancer treatments. Current investments in medical centre development projects will be transferred to the group's wholly owned subsidiary, The Healthcare Property Company, while the firm itself will change its name to Advanced Oncotherapy. The will also be a change in management responsibilities, including the promotion of Lord Evans of Watford to non-executive Chairman.

Try 6 free issues of MoneyWeek today

Get unparalleled financial insight, analysis and expert opinion you can profit from.

Start your trial

https://cdn.mos.cms.futurecdn.net/flexiimages/mw70aro6gl1676370748.jpg

Sign up for MoneyWeek’s free twice-daily newsletter.

Join more than 165,000 subscribers and keep yourself informed with latest financial news, insights and expert analysis to help you understand what really matters when it comes to your finances.

Stockbroking firm Numis Securities is taking over the RBS Hoare Govett Smaller Companies Index. The index will be renamed "The Numis Smaller Companies Index" with immediate effect. Although no initial consideration is being paid, Numis will be paying ongoing fees and may make royalty-based payments to the compilers of the index. The index covers over 800 companies which make up the bottom 10% of the UK market by value.